ENCIRCLE - SAPIEN M3 System TransCatheter MItral Valve ReplaCement via TransseptaL AccEss

Principal Investigator

Study Number

STUDY02001457

Summary

This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

Phase

N/A

Available at the following location(s)

Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms